Jefferies Group's TARS Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 118,810 shares of Tarsus Pharmaceuticals, Inc. (TARS) worth $9.73 M, representing 0.05% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in TARS, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 150,000 shares. Largest reduction occurred in Q1 2025, reducing 341,950 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Tarsus Pharmaceuticals (TARS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tarsus Pharmaceuticals (TARS) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +5,741 | Add 5.08% | 118,810 | $81.88 |
| Q3 2025 | -49,927 | Reduce 30.63% | 113,069 | $59.43 |
| Q2 2025 | +84,188 | Add 106.83% | 162,996 | $40.51 |
| Q1 2025 | -341,950 | Reduce 81.27% | 78,808 | $51.37 |
| Q2 2024 | +150,000 | Add 55.40% | 420,758 | $27.18 |
| Q1 2024 | -110,000 | Reduce 28.89% | 270,758 | $36.35 |
| Q4 2023 | +50,000 | Add 15.12% | 380,758 | $20.25 |
| Q3 2023 | -25,000 | Reduce 7.03% | 330,758 | $17.77 |
| Q2 2023 | -90,000 | Reduce 20.19% | 355,758 | $18.07 |
| Q4 2022 | +445,758 | New Buy | 445,758 | $14.66 |
Jefferies Group's Tarsus Pharmaceuticals Investment FAQs
Jefferies Group first purchased Tarsus Pharmaceuticals, Inc. (TARS) in Q4 2022, acquiring 445,758 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Tarsus Pharmaceuticals, Inc. (TARS) for 13 quarters since Q4 2022.
Jefferies Group's largest addition to Tarsus Pharmaceuticals, Inc. (TARS) was in Q4 2022, adding 445,758 shares worth $6.53 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 118,810 shares of Tarsus Pharmaceuticals, Inc. (TARS), valued at approximately $9.73 M.
As of the Q4 2025 filing, Tarsus Pharmaceuticals, Inc. (TARS) represents approximately 0.05% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Tarsus Pharmaceuticals, Inc. (TARS) was 445,758 shares, as reported at the end of Q4 2022.